These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23729495)

  • 1. Diabetes mellitus with obesity is a predictor of recurrence in patients with non-metastatic renal cell carcinoma.
    Fukushima H; Masuda H; Yokoyama M; Tatokoro M; Yoshida S; Ishioka J; Matsuoka Y; Numao N; Koga F; Saito K; Fujii Y; Kihara K
    Jpn J Clin Oncol; 2013 Jul; 43(7):740-6. PubMed ID: 23729495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of body mass index in Korean patients with renal cell carcinoma.
    Jeon HG; Jeong IG; Lee JH; Lee CJ; Kwak C; Kim HH; Lee SE; Lee E
    J Urol; 2010 Feb; 183(2):448-54. PubMed ID: 20006879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relevance of the clinical-pathological predictive factors in force in chromophobe renal cell cancer].
    Pardo P; Rodríguez-Faba O; Palou J; Algaba F; Breda A; Esquena S; Villavicencio H
    Actas Urol Esp; 2012 Oct; 36(9):527-31. PubMed ID: 22365081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local Tumor Bed Recurrence Following Partial Nephrectomy in Patients with Small Renal Masses.
    Wood EL; Adibi M; Qiao W; Brandt J; Zhang M; Tamboli P; Matin SF; Wood CG; Karam JA
    J Urol; 2018 Feb; 199(2):393-400. PubMed ID: 28941919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival.
    Abu-Ghanem Y; Ramon J; Berger R; Kaver I; Fridman E; Leibowitz-Amit R; Dotan ZA
    World J Surg Oncol; 2017 Nov; 15(1):193. PubMed ID: 29096642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC).
    Fukushima H; Saito K; Yasuda Y; Tanaka H; Patil D; Cotta BH; Patel SH; Master VA; Derweesh IH; Fujii Y
    Clin Genitourin Cancer; 2020 Apr; 18(2):111-116.e1. PubMed ID: 32001181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomes.
    Psutka SP; Heidenreich M; Boorjian SA; Bailey GC; Cheville JC; Stewart-Merrill SB; Lohse CM; Atwell TD; Costello BA; Leibovich BC; Thompson RH
    BJU Int; 2017 Jan; 119(1):116-127. PubMed ID: 27489013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of body mass index in patients undergoing nephrectomy for localized renal tumors.
    Kamat AM; Shock RP; Naya Y; Rosser CJ; Slaton JW; Pisters LL
    Urology; 2004 Jan; 63(1):46-50. PubMed ID: 14751346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity is associated with an improved cancer-specific survival, but an increased rate of postoperative complications after surgery for renal cell carcinoma.
    Rogde AJ; Gudbrandsdottir G; Hjelle KM; Sand KE; Bostad L; Beisland C
    Scand J Urol Nephrol; 2012 Oct; 46(5):348-57. PubMed ID: 22530756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral obesity is associated with better recurrence-free survival after curative surgery for Japanese patients with localized clear cell renal cell carcinoma.
    Kaneko G; Miyajima A; Yuge K; Yazawa S; Mizuno R; Kikuchi E; Jinzaki M; Oya M
    Jpn J Clin Oncol; 2015 Feb; 45(2):210-6. PubMed ID: 25420691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of nutritional deficiency on prognosis of renal cell carcinoma (RCC).
    Ko K; Park YH; Lee JW; Ku JH; Kwak C; Kim HH
    BJU Int; 2013 Oct; 112(6):775-80. PubMed ID: 24028765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of high nuclear grade in patients with pathologic T1a renal cell carcinoma.
    Suzuki K; Mizuno R; Mikami S; Tanaka N; Kanao K; Kikuchi E; Miyajima A; Nakagawa K; Oya M
    Jpn J Clin Oncol; 2012 Sep; 42(9):831-5. PubMed ID: 22811408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microscopic venous invasion in renal cell carcinoma as a predictor of recurrence after radical surgery.
    Ishimura T; Sakai I; Hara I; Eto H; Miyake H
    Int J Urol; 2004 May; 11(5):264-8. PubMed ID: 15147540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: a single-center retrospective study.
    Antonelli A; Arrighi N; Corti S; Zanotelli T; Cozzoli A; Cosciani Cunico S; Simeone C
    Urol Oncol; 2013 Oct; 31(7):1310-5. PubMed ID: 22281433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
    Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-institutional analysis of localized renal cell carcinoma that demonstrates the impact of diabetic status on prognosis after nephrectomy.
    Ha YS; Kim WT; Yun SJ; Lee SC; Kim WJ; Park YH; Kang SH; Hong SH; Byun SS; Kim YJ
    Ann Surg Oncol; 2013 Oct; 20(11):3662-8. PubMed ID: 23907313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hypertension on preoperative neutrophil-lymphocyte ratio evaluation of prognosis of renal cell carcinoma.
    Sun J; Ning H; Sun J; Qu X
    Urol Oncol; 2016 May; 34(5):239.e9-15. PubMed ID: 26803433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for recurrence after surgery in non-metastatic RCC with thrombus: a contemporary multicentre analysis.
    Abel EJ; Margulis V; Bauman TM; Karam JA; Christensen WP; Krabbe LM; Haddad A; Golla V; Wood CG
    BJU Int; 2016 Jun; 117(6B):E87-94. PubMed ID: 26305276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-11 receptor predicts post-operative clinical outcome in patients with early-stage clear-cell renal cell carcinoma.
    Pan D; Xu L; Liu H; Zhang W; Zhu Y; Xu J; Gu J
    Jpn J Clin Oncol; 2015 Feb; 45(2):202-9. PubMed ID: 25420690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial nephrectomy versus radical nephrectomy for non-metastatic pathological T3a renal cell carcinoma: a multi-institutional comparative analysis.
    Oh JJ; Byun SS; Lee SE; Hong SK; Lee ES; Kim HH; Kwak C; Ku JH; Jeong CW; Kim YJ; Kang SH; Hong SH
    Int J Urol; 2014 Apr; 21(4):352-7. PubMed ID: 24118633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.